Literature DB >> 24866805

Host defense peptide resistance contributes to colonization and maximal intestinal pathology by Crohn's disease-associated adherent-invasive Escherichia coli.

Joseph B McPhee1, Cherrie L Small1, Sarah A Reid-Yu1, John R Brannon2, Hervé Le Moual2, Brian K Coombes3.   

Abstract

Host defense peptides secreted by colonocytes and Paneth cells play a key role in innate host defenses in the gut. In Crohn's disease, the burden of tissue-associated Escherichia coli commonly increases at epithelial surfaces where host defense peptides concentrate, suggesting that this bacterial population might actively resist this mechanism of bacterial killing. Adherent-invasive E. coli (AIEC) is associated with Crohn's disease; however, the colonization determinants of AIEC in the inflamed gut are undefined. Here, we establish that host defense peptide resistance contributes to host colonization by Crohn's-associated AIEC. We identified a plasmid-encoded genomic island (called PI-6) in AIEC strain NRG857c that confers high-level resistance to α-helical cationic peptides and α- and β-defensins. Deletion of PI-6 sensitized strain NRG857c to these host defense molecules, reduced its competitive fitness in a mouse model of infection, and attenuated its ability to induce cecal pathology. This phenotype is due to two genes in PI-6, arlA, which encodes a Mig-14 family protein implicated in defensin resistance, and arlC, an OmpT family outer membrane protease. Implicit in these findings are new bacterial targets whose inhibition might limit AIEC burden and disease in the gut.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24866805      PMCID: PMC4136195          DOI: 10.1128/IAI.01888-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  64 in total

1.  Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract.

Authors:  Koichi S Kobayashi; Mathias Chamaillard; Yasunori Ogura; Octavian Henegariu; Naohiro Inohara; Gabriel Nuñez; Richard A Flavell
Journal:  Science       Date:  2005-02-04       Impact factor: 47.728

2.  Reduced Paneth cell alpha-defensins in ileal Crohn's disease.

Authors:  Jan Wehkamp; Nita H Salzman; Edith Porter; Sabine Nuding; Michael Weichenthal; Robert E Petras; Bo Shen; Elke Schaeffeler; Matthias Schwab; Rose Linzmeier; Ryan W Feathers; Hiutung Chu; Heriberto Lima; Klaus Fellermann; Tomas Ganz; Eduard F Stange; Charles L Bevins
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-05       Impact factor: 11.205

3.  Adherent-invasive Escherichia coli phenotype displayed by intestinal pathogenic E. coli strains from cats, dogs, and swine.

Authors:  Margarita Martinez-Medina; Jesus Garcia-Gil; Nicolas Barnich; Lothar H Wieler; Christa Ewers
Journal:  Appl Environ Microbiol       Date:  2011-06-24       Impact factor: 4.792

4.  Salmonella enterica serovar Typhimurium pathogenicity island 2 is necessary for complete virulence in a mouse model of infectious enterocolitis.

Authors:  Bryan Coburn; Yuling Li; David Owen; Bruce A Vallance; B Brett Finlay
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

5.  Antimicrobial resistance-conferring plasmids with similarity to virulence plasmids from avian pathogenic Escherichia coli strains in Salmonella enterica serovar Kentucky isolates from poultry.

Authors:  W Florian Fricke; Patrick F McDermott; Mark K Mammel; Shaohua Zhao; Timothy J Johnson; David A Rasko; Paula J Fedorka-Cray; Adriana Pedroso; Jean M Whichard; J Eugene Leclerc; David G White; Thomas A Cebula; Jacques Ravel
Journal:  Appl Environ Microbiol       Date:  2009-07-31       Impact factor: 4.792

6.  The proinflammatory CXC-chemokines GRO-alpha/CXCL1 and MIG/CXCL9 are concomitantly expressed in ulcerative colitis and decrease during treatment with topical corticosteroids.

Authors:  Arne Egesten; Mette Eliasson; Anders I Olin; Jonas S Erjefält; Anders Bjartell; Per Sangfelt; Marie Carlson
Journal:  Int J Colorectal Dis       Date:  2007-08-17       Impact factor: 2.571

7.  Escherichia coli isolated from a Crohn's disease patient adheres, invades, and induces inflammatory responses in polarized intestinal epithelial cells.

Authors:  Tonyia Eaves-Pyles; Christopher A Allen; Joanna Taormina; Alexander Swidsinski; Christopher B Tutt; G Eric Jezek; Martha Islas-Islas; Alfredo G Torres
Journal:  Int J Med Microbiol       Date:  2007-09-27       Impact factor: 3.473

8.  Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease.

Authors:  L A Simms; J D Doecke; M D Walsh; N Huang; E V Fowler; G L Radford-Smith
Journal:  Gut       Date:  2008-02-27       Impact factor: 23.059

9.  An altered immune response, but not individual cationic antimicrobial peptides, is associated with the oral attenuation of Ara4N-deficient Salmonella enterica serovar Typhimurium in mice.

Authors:  Kristi L Strandberg; Susan M Richards; Rita Tamayo; Linh T Reeves; John S Gunn
Journal:  PLoS One       Date:  2012-11-15       Impact factor: 3.240

10.  The antimicrobial peptide cathelicidin protects mice from Escherichia coli O157:H7-mediated disease.

Authors:  Milan Chromek; Ida Arvidsson; Diana Karpman
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

View more
  23 in total

1.  Adaptation of adherent-invasive E. coli to gut environment: Impact on flagellum expression and bacterial colonization ability.

Authors:  Gwladys Sevrin; Sébastien Massier; Benoit Chassaing; Allison Agus; Julien Delmas; Jérémy Denizot; Elisabeth Billard; Nicolas Barnich
Journal:  Gut Microbes       Date:  2018-03-01

2.  Crohn's disease and sarcoidosis in siblings: follow-up of a published report with a new case and brief review of the literature.

Authors:  J M T Willoughby
Journal:  Frontline Gastroenterol       Date:  2016-01-04

3.  Multifunctional Role of 35 Kilodalton Hyaluronan in Promoting Defense of the Intestinal Epithelium.

Authors:  Sean P Kessler; Dana R Obery; Kourtney P Nickerson; Aaron C Petrey; Christine McDonald; Carol A de la Motte
Journal:  J Histochem Cytochem       Date:  2018-01-01       Impact factor: 2.479

4.  Antimicrobial Peptide Conformation as a Structural Determinant of Omptin Protease Specificity.

Authors:  John R Brannon; Jenny-Lee Thomassin; Samantha Gruenheid; Hervé Le Moual
Journal:  J Bacteriol       Date:  2015-09-08       Impact factor: 3.490

Review 5.  Host-microbe interactions in the small bowel.

Authors:  Julie M Davies; Maria T Abreu
Journal:  Curr Opin Gastroenterol       Date:  2015-03       Impact factor: 3.287

6.  Catestatin selects for colonization of antimicrobial-resistant gut bacterial communities.

Authors:  Pamela González-Dávila; Markus Schwalbe; Arpit Danewalia; Boushra Dalile; Kristin Verbeke; Sushil K Mahata; Sahar El Aidy
Journal:  ISME J       Date:  2022-04-19       Impact factor: 11.217

Review 7.  Understanding host-adherent-invasive Escherichia coli interaction in Crohn's disease: opening up new therapeutic strategies.

Authors:  Allison Agus; Sébastien Massier; Arlette Darfeuille-Michaud; Elisabeth Billard; Nicolas Barnich
Journal:  Biomed Res Int       Date:  2014-12-15       Impact factor: 3.411

8.  CXCL9 contributes to antimicrobial protection of the gut during citrobacter rodentium infection independent of chemokine-receptor signaling.

Authors:  Sarah A Reid-Yu; Brian R Tuinema; Cherrie N Small; Lydia Xing; Brian K Coombes
Journal:  PLoS Pathog       Date:  2015-02-02       Impact factor: 6.823

9.  Antagonism of Adherent Invasive E. coli LF82 With Human α-defensin 5 in the Follicle-associated Epithelium of Patients With Ileal Crohn's Disease.

Authors:  Lina Y Alkaissi; Martin E Winberg; Stéphanie D S Heil; Staffan Haapaniemi; Pär Myrelid; Eduard F Stange; Johan D Söderholm; Åsa V Keita
Journal:  Inflamm Bowel Dis       Date:  2021-06-15       Impact factor: 5.325

Review 10.  The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent.

Authors:  Kylen E Ridyard; Joerg Overhage
Journal:  Antibiotics (Basel)       Date:  2021-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.